Foley Partner Gregory Neppl was quoted in an article that appeared on Bloomberg on March 12, 2010 titled “Monsanto’s Seed Patents May Trump Antitrust Claims, Lawyers Say.” Neppl discusses the antitrust probes facing Monsanto Co. over its genetically modified seeds. He states that where the patent rights are clear, the antitrust issues are often secondary, noting that the antitrust concerns must respect the patent owner.
People
Related News
December 24, 2025
In the News
Kyle Faget on HHS Gender-Affirming Care Declaration – Impact is 'Enormous'
Foley & Lardner LLP partner Kyle Faget commented on the recent Department of Health and Human Services declaration rejecting gender-affirming care in the STAT News article, “Nineteen states, D.C. sue HHS over gender-affirming care crackdown."
December 22, 2025
In the News
Monica Call in Law.com Leadership Spotlight – 'I see my role as both coach and advocate'
Foley & Lardner LLP partner Monica Call reflects on leadership, mentorship, and strategy in Law.com's "How I Made It Office Managing Partner" series.
December 18, 2025
In the News
Kyle Faget Weighs in on HHS Proposed Rule Limiting Gender-Affirming Care
Foley & Lardner LLP partner Kyle Faget commented on a recent proposal from the U.S. Department of Health and Human Services in the Law360 article, “HHS Proposes Hospital Ban On Gender Care For Minors.”